{"name":"Mylan Pharmaceuticals Inc","slug":"mylan-pharmaceuticals-inc","ticker":"","exchange":"","domain":"mylan.com","description":"","hq":"Canonsburg","founded":0,"employees":"","ceo":"Heather Bresch","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":18,"colorKey":"oncology","drugs":[{"name":"Transdermal system containing progestin","genericName":"Transdermal system containing progestin","slug":"transdermal-system-containing-progestin","indication":"Contraception","status":"phase_3"},{"name":"Estradiol Vaginal Cream, 0.01%","genericName":"Estradiol Vaginal Cream, 0.01%","slug":"estradiol-vaginal-cream-0-01","indication":"Vaginal atrophy associated with menopause","status":"phase_3"},{"name":"Fexofenadine Tablets 180 mg","genericName":"Fexofenadine Tablets 180 mg","slug":"fexofenadine-tablets-180-mg","indication":"Other","status":"phase_1"},{"name":"Adoxa Tablets 150 mg","genericName":"Adoxa Tablets 150 mg","slug":"adoxa-tablets-150-mg","indication":"Other","status":"phase_1"},{"name":"Azithromycin Tablets 600 mg","genericName":"Azithromycin Tablets 600 mg","slug":"azithromycin-tablets-600-mg","indication":"Other","status":"phase_1"},{"name":"BALSALAZIDE DISODIUM CAPSULES, 750 MG","genericName":"BALSALAZIDE DISODIUM CAPSULES, 750 MG","slug":"balsalazide-disodium-capsules-750-mg","indication":"Other","status":"phase_1"},{"name":"Dilantin® Kapseals® 100 mg","genericName":"Dilantin® Kapseals® 100 mg","slug":"dilantin-kapseals-100-mg","indication":"Other","status":"phase_1"},{"name":"Estrace® 0.01% cream","genericName":"Estrace® 0.01% cream","slug":"estrace-0-01-cream","indication":"Atrophic vaginitis (vaginal atrophy) associated with menopause","status":"phase_3"},{"name":"Hercules","genericName":"Hercules","slug":"hercules","indication":"Other","status":"phase_1"},{"name":"MYL-1701P","genericName":"MYL-1701P","slug":"myl-1701p","indication":"Chemotherapy-induced neutropenia in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy","status":"phase_3"},{"name":"Metoprolol Tartrate Tablets 25 mg","genericName":"Metoprolol Tartrate Tablets 25 mg","slug":"metoprolol-tartrate-tablets-25-mg","indication":"Other","status":"phase_1"},{"name":"Nisoldipine Extended-release Tablets, 30 mg","genericName":"Nisoldipine Extended-release Tablets, 30 mg","slug":"nisoldipine-extended-release-tablets-30-mg","indication":"Other","status":"phase_1"},{"name":"Ondansetron Orally Disintegrating Tablets 8 mg","genericName":"Ondansetron Orally Disintegrating Tablets 8 mg","slug":"ondansetron-orally-disintegrating-tablets-8-mg","indication":"Other","status":"phase_1"},{"name":"Oxybutynin Chloride Extended-Release Tablets, 15 mg","genericName":"Oxybutynin Chloride Extended-Release Tablets, 15 mg","slug":"oxybutynin-chloride-extended-release-tablets-15-mg","indication":"Other","status":"phase_1"},{"name":"Pioglitazone HCl Tablets 45 mg","genericName":"Pioglitazone HCl Tablets 45 mg","slug":"pioglitazone-hcl-tablets-45-mg","indication":"Other","status":"phase_1"},{"name":"Topamax® Sprinkle Capsules 25 mg","genericName":"Topamax® Sprinkle Capsules 25 mg","slug":"topamax-sprinkle-capsules-25-mg","indication":"Other","status":"phase_1"},{"name":"Topiramate Sprinkle Capsules 25 mg","genericName":"Topiramate Sprinkle Capsules 25 mg","slug":"topiramate-sprinkle-capsules-25-mg","indication":"Other","status":"phase_1"},{"name":"Valtrex® 1000 mg","genericName":"Valtrex® 1000 mg","slug":"valtrex-1000-mg","indication":"Other","status":"phase_1"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Bevacizumab as Avastin","genericName":"Bevacizumab as Avastin","slug":"bevacizumab-as-avastin","indication":"Metastatic colorectal cancer","status":"phase_3"},{"name":"Bevacizumab as MYL-1402O","genericName":"Bevacizumab as MYL-1402O","slug":"bevacizumab-as-myl-1402o","indication":"Metastatic colorectal cancer","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"MYL-1701P, a proposed biosimilar to Eylea","genericName":"MYL-1701P, a proposed biosimilar to Eylea","slug":"myl-1701p-a-proposed-biosimilar-to-eylea","indication":"Neovascular (wet) age-related macular degeneration","status":"phase_3"}]}],"pipeline":[{"name":"Transdermal system containing progestin","genericName":"Transdermal system containing progestin","slug":"transdermal-system-containing-progestin","phase":"phase_3","mechanism":"A transdermal progestin delivery system that releases the hormone through the skin to provide contraceptive and/or hormone replacement effects.","indications":["Contraception","Hormone replacement therapy (if applicable to specific formulation)"],"catalyst":""},{"name":"Estradiol Vaginal Cream, 0.01%","genericName":"Estradiol Vaginal Cream, 0.01%","slug":"estradiol-vaginal-cream-0-01","phase":"phase_3","mechanism":"Estradiol vaginal cream delivers the hormone estrogen directly to vaginal tissues to relieve symptoms of vaginal atrophy and genitourinary syndrome of menopause.","indications":["Vaginal atrophy associated with menopause","Genitourinary syndrome of menopause (GSM)"],"catalyst":""},{"name":"Fexofenadine Tablets 180 mg","genericName":"Fexofenadine Tablets 180 mg","slug":"fexofenadine-tablets-180-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Adoxa Tablets 150 mg","genericName":"Adoxa Tablets 150 mg","slug":"adoxa-tablets-150-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Azithromycin Tablets 600 mg","genericName":"Azithromycin Tablets 600 mg","slug":"azithromycin-tablets-600-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BALSALAZIDE DISODIUM CAPSULES, 750 MG","genericName":"BALSALAZIDE DISODIUM CAPSULES, 750 MG","slug":"balsalazide-disodium-capsules-750-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Bevacizumab as Avastin","genericName":"Bevacizumab as Avastin","slug":"bevacizumab-as-avastin","phase":"phase_3","mechanism":"Bevacizumab is a monoclonal antibody that blocks vascular endothelial growth factor (VEGF), preventing tumor blood vessel formation and starving tumors of oxygen and nutrients.","indications":["Metastatic colorectal cancer","Metastatic non-small cell lung cancer","Metastatic breast cancer","Glioblastoma","Metastatic renal cell carcinoma"],"catalyst":""},{"name":"Bevacizumab as MYL-1402O","genericName":"Bevacizumab as MYL-1402O","slug":"bevacizumab-as-myl-1402o","phase":"phase_3","mechanism":"MYL-1402O is a biosimilar of bevacizumab that inhibits vascular endothelial growth factor (VEGF) to block tumor angiogenesis and reduce blood supply to cancer cells.","indications":["Metastatic colorectal cancer","Metastatic non-small cell lung cancer","Metastatic breast cancer","Glioblastoma","Metastatic renal cell carcinoma"],"catalyst":""},{"name":"Dilantin® Kapseals® 100 mg","genericName":"Dilantin® Kapseals® 100 mg","slug":"dilantin-kapseals-100-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Estrace® 0.01% cream","genericName":"Estrace® 0.01% cream","slug":"estrace-0-01-cream","phase":"phase_3","mechanism":"Estrace cream delivers estradiol, a natural estrogen, directly to vaginal and vulvar tissues to relieve symptoms of atrophic vaginitis and urogenital atrophy.","indications":["Atrophic vaginitis (vaginal atrophy) associated with menopause","Urogenital atrophy symptoms including vaginal dryness and dyspareunia"],"catalyst":""},{"name":"Hercules","genericName":"Hercules","slug":"hercules","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"MYL-1701P","genericName":"MYL-1701P","slug":"myl-1701p","phase":"phase_3","mechanism":"MYL-1701P is a biosimilar of pegfilgrastim that stimulates neutrophil production to prevent chemotherapy-induced neutropenia.","indications":["Chemotherapy-induced neutropenia in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy"],"catalyst":""},{"name":"MYL-1701P, a proposed biosimilar to Eylea","genericName":"MYL-1701P, a proposed biosimilar to Eylea","slug":"myl-1701p-a-proposed-biosimilar-to-eylea","phase":"phase_3","mechanism":"MYL-1701P is a biosimilar to aflibercept that binds vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) to inhibit pathological neovascularization in the eye.","indications":["Neovascular (wet) age-related macular degeneration","Retinal vein occlusion","Diabetic macular edema"],"catalyst":""},{"name":"Metoprolol Tartrate Tablets 25 mg","genericName":"Metoprolol Tartrate Tablets 25 mg","slug":"metoprolol-tartrate-tablets-25-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Nisoldipine Extended-release Tablets, 30 mg","genericName":"Nisoldipine Extended-release Tablets, 30 mg","slug":"nisoldipine-extended-release-tablets-30-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ondansetron Orally Disintegrating Tablets 8 mg","genericName":"Ondansetron Orally Disintegrating Tablets 8 mg","slug":"ondansetron-orally-disintegrating-tablets-8-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Oxybutynin Chloride Extended-Release Tablets, 15 mg","genericName":"Oxybutynin Chloride Extended-Release Tablets, 15 mg","slug":"oxybutynin-chloride-extended-release-tablets-15-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Pioglitazone HCl Tablets 45 mg","genericName":"Pioglitazone HCl Tablets 45 mg","slug":"pioglitazone-hcl-tablets-45-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Topamax® Sprinkle Capsules 25 mg","genericName":"Topamax® Sprinkle Capsules 25 mg","slug":"topamax-sprinkle-capsules-25-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Topiramate Sprinkle Capsules 25 mg","genericName":"Topiramate Sprinkle Capsules 25 mg","slug":"topiramate-sprinkle-capsules-25-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Valtrex® 1000 mg","genericName":"Valtrex® 1000 mg","slug":"valtrex-1000-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOVDN3WjZLdFRadFN0SGhNcTBGbDRKd1JkelNtY09jRHdrRGJHVndHdTJwLWRvOXVaX2ZYeGdkOUw2cXpnbmd4STNRSXlrTUhlZ1plNm10ZC14NTN5b2JaRVZxY3FZU0tNTVlpSUVRZ3EwVDRGMWczUnI0WDhySVJBWVRROHFpblFQeG5RXzVJN1UtZk52MzZKYUNHMExRcFo50gFWQVVfeXFMT1hMVGVWX2NuTXBhSTZUbk9leDJnN2Z2UExLNVVLZUdsd2VpUXBJVVlOekRKUTdJLXF2dXM2US1lWTU1OE9icVJqaFg2VEZpV21OSDk5N0E?oc=5","date":"2025-11-24","type":"patent","source":"Law360","summary":"Full Fed. Circ. Rejects Bayer Petition In Xarelto Patent Case - Law360","headline":"Full Fed. Circ. Rejects Bayer Petition In Xarelto Patent Case - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOMXZwcUF2eWNSaHh2MVY4SlVxN25lSVQ4c2VQS3FzYndfdGk5aWFFUXdRZGtYT0IzeEJob3hUSXVZSjlpcU5uRWRnMXBOd3JVakxpRGpLUjdxYmJISGlXN2EwaWtmaGlKTGh6dGIxQXZRSDJ3c3dxckc0MEJNZ0tuMVk1R25aUVlndlVaSTM0X2FuZnBKelpUdmZtcWNCY3JIT0pyRW56aWFRcDdoTVhFaGtZNXNxWHBZQ0dhZWVVX3luNG9yUWxoS1Y1VXRBWFFfUE0wMw?oc=5","date":"2025-10-01","type":"trial","source":"Jones Day","summary":"Federal Circuit: When and How to Patent Around Clinical Trials - Jones Day","headline":"Federal Circuit: When and How to Patent Around Clinical Trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxQVHdleDB5YUJiWDJGczNoSDRWa0Rmb051YTBLd3hIM01BMGdrYVlSbUtrLWdQNnFfb29pbUlSOWw3SmpSanVXSzZkTTRzalpISlFfdktsUkk5bGp6dE9kVlg0WmxfVjhsdHYxUkN3MC1UUV9FdVlsWXI4MXJYYzhqWWhUVm5QMjl6M3FXS2pQOXJjcjJSYlBwY3ktV1hlYUhOUWtyVHplb2NfWUprNmZpcW5rZjZ3QTJQSDFQdjl6aGM0ckg2YmcwZE55aTNSRGtKaS1KUWJSdU56elFjVklfd2JhYmdjeUJzM3EzOUs4QzA0aHpGZnBYV01nRjY5QXEzYy12aEJ4bVNQMEswWjVqaWVPbXJOSl8zczZMbmJZMnFlRE96QlFpNkhqd1AtVkZaN0ExUm1DZmxxc28?oc=5","date":"2025-09-25","type":"patent","source":"akingump.com","summary":"Federal Circuit: The Term 'Clinically Proven Effective' Amount Does Not Impart Patentability Over Prior Art for Claims That Also Recite Specific Numerical Dosages - akingump.com","headline":"Federal Circuit: The Term 'Clinically Proven Effective' Amount Does Not Impart Patentability Over Prior Art for Claims T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOQkxYaTJGM1oySFpndVdSMmpiS2g4SERhUVduNmxTU1MwaUxkc3ZoYkI2cGxTeExPQVVrOFdVbjVVaVFqY1IzRnI4Wkw0ZUR1YXBYYWhmVzZPM1A0dG1vUUNSQTlQSEE1NE5NNHpIYUJfMWhvV2huRXZxY0lqRlFlZmpXOEVDT0FWM3lYcWZiWF9FeWJOck1GQTVDcUxfZlA2Tm1pR1pkRmh5X3N4VEVYOTJuXzloS1o5UXA1MWhOX1RfNDFBMHRqUVFLdw?oc=5","date":"2025-04-07","type":"pipeline","source":"NCDOJ (.gov)","summary":"Attorney General Jeff Jackson Wins up to $335 Million from Pharmaceutical Company Mylan for Fueling Opioid Crisis - NCDOJ (.gov)","headline":"Attorney General Jeff Jackson Wins up to $335 Million from Pharmaceutical Company Mylan for Fueling Opioid Crisis - NCDO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQZUlIRUhQdll1aVk2c3FIbUFjaHFuMzVJS1MydFg5YUZMb01wQk1sVmJtd19pRWtLZTBMdmw2d3hFMVZTdHg1Y2JWUzVKYVQtRUhmMUxxUUdZaWx4VWVOWUk5OFo1b3J6THNTTWhJZEdpeWFESkdNT1p4aElfZmNaQkdLTlU3bmJ0Y08weE1nQ1lZSS1wd3NZaXNCT1lhbVktYktSYjF0allRbU5nSHk4OVItd0liV2xxa092RklLY2tsUTlf?oc=5","date":"2025-04-07","type":"pipeline","source":"Delawareonline.com","summary":"Delaware will receive portion of $335M settlement with opioid manufacturer Mylan Inc. - Delawareonline.com","headline":"Delaware will receive portion of $335M settlement with opioid manufacturer Mylan Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxPOE5Sbld0eGd0VU9HeXFsWXhnX3piaGZVSVNVRHhIcTk1U0lJQm84Nmw1OUxsWXdKVDM0MDc5VjRqYzB2bkxoSEt3UHJGNTJQNDA4ZkpuaGVlV2hkb01vdDdwVVRrVlVUWUFIR3dMcVZTM2pYR3VkNHE0cGRDcURrbzhWMXlVcmpKaHlTaG1iMy1DWkNGaVZEYmlMZE44Qnk0OTUwQ0pScXdVT3NVZlZoSk1sQjFWRGR6QzhLNUwxTi0xM3JVR2d3RGhleWt0a1Z6b0hxUUgxejc?oc=5","date":"2025-03-17","type":"pipeline","source":"Class Action Lawsuits","summary":"$73.5M Mylan Pharmaceuticals EpiPen monopoly class action settlement - Class Action Lawsuits","headline":"$73.5M Mylan Pharmaceuticals EpiPen monopoly class action settlement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPVVBHNmtKVjU2emJIWVp1bE5MaEo1T3FJcHBWUGpXcWljdENKbE5EMG1zWjJITk1hUDRmRDN3VjZCaDAwWmtmMTRIaXp2WWx5czFyODNhdGZtOVNkR3lfbnI0QXhCclBQeWp1cGlCZzlyRkRBOWJ3ODdGWXhyaFM3U0ljelhrdkJqQjBCQl9FZUdTRjZONDlLbl9kalFzSXhsTThFdE9EV1NqNjhCU3pEVXdPa1lFU2M?oc=5","date":"2024-10-07","type":"patent","source":"Fierce Pharma","summary":"Amid GLP-1 craze, Novo and Mylan ink patent settlement in Ozempic case - Fierce Pharma","headline":"Amid GLP-1 craze, Novo and Mylan ink patent settlement in Ozempic case","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxOa3Q1RzZYVXRVTUZZWXBTN3BSc2hpZGZzQlFUdUFDUUFVUzJpM3RjNmxvN3JBWjBNaHJUVTJveUdNVTBjMjJmdlRIekVPRnVyeHNYLTBOZ0ltU3EyNVI5Sy1uQkt0NkVnQVRhRnRIbE84TVVKZEMzajdlNjUxYzF4TVpnWk8wVm1IYmIwLTV4cHVCT013NTF3SXNRVXo0UDBkUjlYSWc0Y0V4eVhlRVBNRTRIWHdNVEt5YWZ5dzY3WXp2OTV6LXFiRUlWa2diSkhDdUdmbXpxcFA0TjFOdGVTV191WEt1Z2hZQ3ppdTFOTDVXUQ?oc=5","date":"2023-11-11","type":"pipeline","source":"WV News","summary":"WVU Innovation Corporation revitalizes former Mylan Pharmaceutical building - WV News","headline":"WVU Innovation Corporation revitalizes former Mylan Pharmaceutical building","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQT1FIQ3F4WU5Jb2Z6aElaR2tLYk1sbHpseldjZ3BtMm1wcDg2N0pLdlVTUjg3cWZhemF5SGN0S3FuRE9kMlhmRV9WVlcxci12LVh3UVFZOU95a2RGZGdxY3F0U2l4c18zbkNjVjhkdEY1VmczVnczSTRKeC1pUk95VXVKM0NVdVlfSDFHNHZKaHM4VTNGZVhfOWdLNTQ0QVRJWnpHUVY1Mk0?oc=5","date":"2021-08-10","type":"pipeline","source":"Mountain State Spotlight","summary":"Morgantown pharmaceutical plant’s fall started long ago - Mountain State Spotlight","headline":"Morgantown pharmaceutical plant’s fall started long ago","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNQnZJdW4wRVl0a0xIb0hPNGs4NHluVnZfNWdET3hHdE5waXpvNzJJQTY0VFpUbFJrNzFPX1VmQ0xQMUhHNEthRWVsQWV4eUF1YmdJQWpzaGZHd2ZodWFFT3JWU3R5SjhUMjRqa2NGS3I1cGs4M3B6TkY5QVBSdDhtVk1iYmd2MG0teHJ6bjdNT2RsaWVubVVoSWVvNlE3bFhiVDVqZ0puMEg3MjFsSzhFbTBpaVlOd1lpUnVJaQ?oc=5","date":"2020-11-12","type":"pipeline","source":"Mintz","summary":"In Hatch-Waxman litigation, Federal Circuit restricts venue under the TC Heartland to districts relating to ANDA filings - Mintz","headline":"In Hatch-Waxman litigation, Federal Circuit restricts venue under the TC Heartland to districts relating to ANDA filings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOVGE3XzVsQS1iYTM3dWc3TWZSck9KLXpDUS1ZY3dmeDd3ZjlCWXRpbWlhdTZZRVgwLUpsSFFuT1oyekNKck9FcllBT1EtLXJlTUlKLTlVS09JRlBlZjBsbGF5ek1Jbjd6N3FGNEF5ZUI2dEVwZGxQMUIzU01CblVQY3drbUFrRE5GY1FObkY2TllxUUtJeVdvSDh0cnN1cFE3cjZ0RHA4QXp4ekRzcXNwRWY0bWF2bWc?oc=5","date":"2020-06-12","type":"patent","source":"Ohio Attorney General (.gov)","summary":"Yost Takes Action Against Generic Drug Manufacturers Who Conspired to Inflate, Manipulate Prices - Ohio Attorney General (.gov)","headline":"Yost Takes Action Against Generic Drug Manufacturers Who Conspired to Inflate, Manipulate Prices - Ohio Attorney General","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxOdjJkUTlwM1psUm8xTjh2VllXMnJ6cGFvZTdSS1l4M1ZKQjlSa0kySU9NSnQ4VHFjMWNCeU1HcmgtVzJ2cktzcHd5UW81YjBTM1BjRm9yVU5zSmxCdDRXSDNJTDBJckNXMFAxaVpSdXRram1OazkyV2I1U29tTDRiNy01SEZISmVaTWFXX1BnTWFfQ0hhM3p4UUpLQ3NPLWI3R0ctNWRvVXZqUFVSOGJhZVgyT3c5LXFmcUZLMm53Z05wd0Ntc2g2emcxdFpOVUNLaVVCUmVwUlduSHdybFQ0N0RUT3gyU3RVQlIybGluLW93dw?oc=5","date":"2019-05-12","type":"patent","source":"portal.ct.gov","summary":"TONG LEADS LAWSUIT AGAINST GENERIC DRUG MANUFACTURERSIN CONSPIRACY TO FIX PRICES FOR OVER 100 DRUGS - portal.ct.gov","headline":"TONG LEADS LAWSUIT AGAINST GENERIC DRUG MANUFACTURERSIN CONSPIRACY TO FIX PRICES FOR OVER 100 DRUGS","sentiment":"neutral"}],"patents":[],"drugCount":21,"phaseCounts":{"phase_3":7,"phase_1":14},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}